179 related articles for article (PubMed ID: 35272430)
1. [The effect of prealbumin on the long-term prognosis of hilar cholangiocarcinoma following radical surgery].
Chen ZY; Liu ZP; Dai HS; Jiang Y; He Y
Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):378-386. PubMed ID: 35272430
[No Abstract] [Full Text] [Related]
2. Elevated preoperative CA125 levels predicts poor prognosis of hilar cholangiocarcinoma receiving radical surgery.
Xu ZL; Ou YJ; Dai HS; Wan K; Bie P; Chen ZY; Zhang LD; Zhang CC
Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101695. PubMed ID: 34147661
[TBL] [Abstract][Full Text] [Related]
3. [Robotic hilar cholangiocarcinoma radical resection compared with laparotomy in prognosis].
Chou S; Chang ZY; Zhao GD; Song DD; Zhang X; Hu MG; Liu R
Zhonghua Wai Ke Za Zhi; 2020 Mar; 58(3):230-234. PubMed ID: 32187928
[No Abstract] [Full Text] [Related]
4. [Surgical treatment and prognosis analysis of hilar cholangiocarcinoma].
Li XC; Li CX; Zhang H; Cheng F; Zhang F; Pu LY; Zhang CY; Wang K; Kong LB; Qian XF; Li DH; Lu WX; Wang P; Yao AH; Bai JF; Wu XF; Chen RX; Wang XH
Zhonghua Wai Ke Za Zhi; 2024 Apr; 62(4):290-301. PubMed ID: 38432670
[No Abstract] [Full Text] [Related]
5. [Clinical application of combined hepatic artery resection and reconstruction in surgical treatment for hilar cholangiocarcinoma].
Dai HS; Bie P; Wang SG; He Y; Li DJ; Tian F; Zhao X; Chen ZY
Zhonghua Wai Ke Za Zhi; 2018 Jan; 56(1):41-46. PubMed ID: 29325352
[No Abstract] [Full Text] [Related]
6. Defining Early Recurrence of Hilar Cholangiocarcinoma After Curative-intent Surgery: A Multi-institutional Study from the US Extrahepatic Biliary Malignancy Consortium.
Zhang XF; Beal EW; Chakedis J; Chen Q; Lv Y; Ethun CG; Salem A; Weber SM; Tran T; Poultsides G; Son AY; Hatzaras I; Jin L; Fields RC; Buettner S; Scoggins C; Martin RCG; Isom CA; Idrees K; Mogal HD; Shen P; Maithel SK; Schmidt CR; Pawlik TM
World J Surg; 2018 Sep; 42(9):2919-2929. PubMed ID: 29404753
[TBL] [Abstract][Full Text] [Related]
7. [A novel nomogram for individualized preoperative prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma].
Ma WH; Lei ZQ; Yu QS; Xiao QR; Tang HL; Si AF; Yang PH; Cheng ZJ
Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):363-371. PubMed ID: 35272428
[No Abstract] [Full Text] [Related]
8. Evaluation of Four Lymph Node Classifications for the Prediction of Survival in Hilar Cholangiocarcinoma.
Liu ZP; Zhang QY; Chen WY; Huang YY; Zhang YQ; Gong Y; Jiang Y; Bai J; Chen ZY; Dai HS
J Gastrointest Surg; 2022 May; 26(5):1030-1040. PubMed ID: 34973138
[TBL] [Abstract][Full Text] [Related]
9. Postoperative morbidity adversely impacts oncological prognosis after curative resection for hilar cholangiocarcinoma.
Liu ZP; Chen WY; Zhang YQ; Jiang Y; Bai J; Pan Y; Zhong SY; Zhong YP; Chen ZY; Dai HS
World J Gastroenterol; 2022 Mar; 28(9):948-960. PubMed ID: 35317056
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.
Hu HJ; Mao H; Shrestha A; Tan YQ; Ma WJ; Yang Q; Wang JK; Cheng NS; Li FY
World J Gastroenterol; 2016 Feb; 22(8):2601-10. PubMed ID: 26937148
[TBL] [Abstract][Full Text] [Related]
11. [Impact of adjuvant chemotherapy on prognosis in intrahepatic cholangiocarcinoma patients underwent radical resection].
Su JB; Zhang JW; Chen C; Qiu YH; Wu H; Song TQ; He Y; Mao XH; Zhai WL; Cheng ZJ; Li JD; Si SB; Cai ZQ; Geng ZM; Tang Z
Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):356-362. PubMed ID: 35272427
[No Abstract] [Full Text] [Related]
12. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
[TBL] [Abstract][Full Text] [Related]
13. [Biopathological characteristics of hilar cholangiocarcinoma and the clinical significance].
Yu WL; Zhang YJ; Dong H; Yu H; Xian ZH; Wu MC; Cong WM
Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1162-6. PubMed ID: 20021908
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma.
Su CH; Tsay SH; Wu CC; Shyr YM; King KL; Lee CH; Lui WY; Liu TJ; P'eng FK
Ann Surg; 1996 Apr; 223(4):384-94. PubMed ID: 8633917
[TBL] [Abstract][Full Text] [Related]
15. [The clinical value of classification of hilar cholangiocarcinoma based on actual anatomy].
Peng SY; Liu YB; Li XS; Wu Y; Jin YQ; Yu XA; Wang W; Gong W
Zhonghua Wai Ke Za Zhi; 2022 Sep; 60(9):860-865. PubMed ID: 36058713
[No Abstract] [Full Text] [Related]
16. Survival analysis of laparoscopic surgery and open surgery for hilar cholangiocarcinoma: a retrospective cohort study.
Yin Y; Tao J; Xian Y; Hu J; Li Y; Li Q; Xiong Y; He Y; He K; Li J
World J Surg Oncol; 2024 Feb; 22(1):58. PubMed ID: 38369496
[TBL] [Abstract][Full Text] [Related]
17. [A multicenter clinical analysis of short-term efficacy of laparoscopic radical resection of hilar cholangiocarcinoma].
Xu J; Xiong YF; Huang XJ; Yang FC; Li JD; Liu JH; Zhao WX; Qin RY; Yin XM; Zheng SG; Liang X; Peng B; Zhang QF; Li DW; Tang ZH
Zhonghua Wai Ke Za Zhi; 2020 Oct; 58(10):758-764. PubMed ID: 32993262
[No Abstract] [Full Text] [Related]
18. Vascular invasion and lymph node metastasis mediate the effect of CA242 on prognosis in hilar cholangiocarcinoma patients after radical resection.
Heng G; Huang B; Shen Y; Wang D; Lan Z; Yao Y; Zhang J; Jia J; Zhang C
Front Oncol; 2022; 12():1071439. PubMed ID: 36578939
[TBL] [Abstract][Full Text] [Related]
19. Can preoperative and postoperative CA19-9 levels predict survival and early recurrence in patients with resectable hilar cholangiocarcinoma?
Wang JK; Hu HJ; Shrestha A; Ma WJ; Yang Q; Liu F; Cheng NS; Li FY
Oncotarget; 2017 Jul; 8(28):45335-45344. PubMed ID: 28484084
[TBL] [Abstract][Full Text] [Related]
20. [The safety and effect of transhepatic hilar approach for the treatment of bismuth type Ⅲ and Ⅳ hilar cholangiocarcinoma].
He M; Wang HL; Yan JY; Xu SW; Chen W; Wang J
Zhonghua Wai Ke Za Zhi; 2018 May; 56(5):360-366. PubMed ID: 29779312
[No Abstract] [Full Text] [Related]
[Next] [New Search]
